Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 11808
TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649500(US11891386, Compound ARI-120)
Affinity DataIC50: 0.300nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649497(US11891386, Compound ARI-083)
Affinity DataIC50: 0.300nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649499(US11891386, Compound ARI-118)
Affinity DataIC50: 0.800nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649495(US11891386, Compound ARI-056)
Affinity DataIC50: 4.90nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649503(US11891386, Compound ARI-148)
Affinity DataIC50: 5.90nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649487(US11891386, Compound ARI-067)
Affinity DataIC50: 6.30nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649498(US11891386, Compound ARI-090)
Affinity DataIC50: 8.40nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649489(US11891386, Compound ARI-140)
Affinity DataIC50: 8.60nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649505(US11891386, Compound ARI-049)
Affinity DataIC50: 10.1nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649502(US11891386, Compound ARI-146)
Affinity DataIC50: 13.4nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649506(US11891386, Compound ARI-065)
Affinity DataIC50: 14nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649491(US11891386, Compound ARI-143)
Affinity DataIC50: 18.8nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649488(US11891386, Compound ARI-087)
Affinity DataIC50: 25.4nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649492(US11891386, Compound ARI-149)
Affinity DataIC50: 30.3nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM50506039(CHEMBL1324296 | US11891386, Compound 002)
Affinity DataIC50: 31.8nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM50506039(CHEMBL1324296 | US11891386, Compound 002)
Affinity DataIC50: 38.2nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649493(US11891386, Compound ARI-030)
Affinity DataIC50: 40nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649494(US11891386, Compound ARI-031)
Affinity DataIC50: 42.6nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649501(US11891386, Compound ARI-145)
Affinity DataIC50: 46.9nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649485(US11891386, Compound ARI-066)
Affinity DataIC50: 48.6nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649482(US11891386, Compound ARI-055)
Affinity DataIC50: 73.6nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649496(US11891386, Compound ARI-060)
Affinity DataIC50: 110nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649490(US11891386, Compound ARI-142)
Affinity DataIC50: 209nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM50605060(CHEMBL5198290 | US11891386, Compound 004)
Affinity DataIC50: 231nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent